Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,120,241 papers from all fields of science
Search
Sign In
Create Free Account
TGFBR1 gene
Known as:
ALK-5
, ACTIVIN RECEPTOR-LIKE KINASE 5
, TGFBR1
Expand
This gene is involved in transcriptional regulation and cell cycle progression regulation.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Cell Cycle Progression
Ligand Binding
Phosphorylation
Receptor Signaling
Expand
Narrower (1)
TGFBR1 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Efficacy of ALK 5 inhibition in myelofibrosis
L. Yue
,
M. Bartenstein
,
+17 authors
P. Epling-Burnette
2017
Corpus ID: 2590527
1Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. 2Department of Hematology…
Expand
2017
2017
ALK5 kinase inhibitory activity and synthesis of 2,3,4-substituted 5,5-dimethyl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazoles.
E. Řezníčková
,
L. Tenora
,
+6 authors
V. Kryštof
European journal of medicinal chemistry
2017
Corpus ID: 32296942
2016
2016
FGF 2 inhibits endothelial-mesenchymal transition through microRNA-20 a-mediated repression of canonical TGF-beta signaling
Ana C. P. Correia
,
J. Moonen
,
Marja G. L. Brinker
,
G. Krenning
2016
Corpus ID: 96462319
Endothelial-to-mesenchymal transition (EndMT) is characterized by the loss of endothelial cell markers and functions, and…
Expand
2014
2014
Antibacterials for any target
L. Silver
Nature Biotechnology
2014
Corpus ID: 16135686
RNA-guided nucleases provide a strategy for killing specific bacterial species in complex populations.
2013
2013
Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles as inhibitors of transforming growth factor-β type I receptor (ALK5).
Changbin Guo
,
Chong Zhang
,
+6 authors
Song Li
Bioorganic & Medicinal Chemistry Letters
2013
Corpus ID: 27923779
2009
2009
Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5).
Xingzhou Li
,
Li-li Wang
,
Long Long
,
Jun-hai Xiao
,
Yuan-dong Hu
,
Song Li
Bioorganic & Medicinal Chemistry Letters
2009
Corpus ID: 19322279
2009
2009
The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer
G. Colleran
,
N. Mcinerney
,
+7 authors
E. Sawyer
Breast Cancer Research and Treatment
2009
Corpus ID: 24252650
A polymorphic 9-bp deletion in exon 1 of TGFBR1 (TGFBR1*6A) has been identified as a low-penetrance cancer susceptibility allele…
Expand
2005
2005
Adopting a Practical Statistical Approach for Evaluating Assay Agreement in Drug Discovery
Dongyu Sun
,
A. Whitty
,
+4 authors
Serene Josiah
Journal of biomolecular screening
2005
Corpus ID: 25086770
The authors assess the equivalence of 2 assays and put forward a general approach for assay agreement analysis that can be…
Expand
1998
1998
A constitutive mutation of ALK5 disrupts cardiac looping and morphogenesis in mice.
M. Charng
,
P. Frenkel
,
+5 authors
M. Schneider
Developmental Biology
1998
Corpus ID: 41574416
TGF beta family members are implicated in cardiac organogenesis, growth control, and positional information, including the…
Expand
1995
1995
Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Toru Takumi
,
A. Moustakas
,
Herbert Y. Lin
,
H. F. Lodish
Experimental Cell Research
1995
Corpus ID: 33139173
GH3 pituitary tumor cells have surface receptors for transforming growth factors-beta (TGF-beta s) and activins/inhibins. GH3…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE